Catalyst
Slingshot members are tracking this event:
Top-line results from the MEDALIST and BELIEVE Phase 3 trials of luspatercept are expected in mid-2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| XLRN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 28, 2018
Occurred Source:
http://investor.acceleronpharma.com/news-releases/news-release-details/celgene-and-acceleron-announce-luspatercept-achieved-primary-and
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Myelodysplastic Syndromes, Beta-thalassemia, Phase 3 Study, Luspatercept
